Are you Dr. Visnegarwala?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 26 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2484 Briarcliff Rd Ne
Suite 24
Atlanta, GA 30329Phone+1 404-231-4431Fax+1 404-231-5677
Summary
- Dr. Fehmida Visnegarwala, MD is an infectious disease specialist in Atlanta, Georgia. She is currently licensed to practice medicine in Georgia and Texas.
Education & Training
Baylor College of MedicineFellowship, Infectious Disease, 1995 - 1997
Ascension Illinois/Saint FrancisResidency, Internal Medicine, 1991 - 1994
Stanley Medical College SMCClass of 1989
Certifications & Licensure
TX State Medical License 1995 - 2017
GA State Medical License 2007 - 2014
Publications & Presentations
PubMed
- 1903 citationsCirculating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a c...Daniel D Murray, Kazuo Suzuki, Matthew Law, Jonel Trebicka, Jacquie Neuhaus
Plos One. 2015-10-14 - 3 citationsPredictors of HIV positivity among pregnant women presenting for obstetric care in South India - a case-control study.Eileen Solomon, Fehmida Visnegarwala, Philimol Philip, Glory Alexander
AIDS Care. 2011-06-16 - 8 citationsEffects of rosiglitazone on abnormal lipid kinetics in HIV-associated dyslipidemic lipodystrophy: a stable isotope studyRajagopal V. Sekhar, Sanjeet G. Patel, Susana D'Amico, Jianjian Shi, Ashok Balasubramanyam
Metabolism. 2011-06-01
Grant Support
- Role Of Rosiglitazone In The Pathogenesis Of HIV LipodystrophyNational Center For Research Resources2005
- Rosiglitazone In The Pathogenesis Of HIV LipodystrophyNational Center For Research Resources2004
